DURHAM, N.C. – A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report. The finding clears the way for the new monoclonal antibody to move forward in human clinical trials. Results of the study appear online Aug. 30 in the journal Science Translational Medicine.

Pritzker Molecular Engineering researchers led by Prof. Jeffrey Hubbell showed that their compound can eliminate the autoimmune reaction associated with multiple sclerosis.

Britain's state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three quarters. Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England

The new blood test could allow Parkinson’s disease to be diagnosed and treated earlier

The etiology of Parkinson's disease (PD) is multifactorial, with genetics, aging, and environmental agents all a part of the PD pathogenesis. Widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy neurites, and degeneration of substantia nigra dopamine neurons are the …

Bacteriophages have been a mainstay in medical centers abroad for some time now. Georgia’s Eliava Institute has been active since the 1930s. Yet countries including the U.S. and U.K. grant access almost exclusively under compassionate use. That means bacteriophages have been languishing for decades as a last-ditch option.

Past public ire over high drug prices has recently taken a back seat to a more insidious problem – no drugs at any price.

If the United States of America had the same mortality rates as other wealthy countries, more than 1 million people would have avoided death in 2021, a new study found.

Conjoined twins are finally going home after the pair was safely separated during a complex surgery at Texas Children’s Hospital in June.

A long-awaited vaccine for malaria has been announced for rollout across 12 African countries over the next two years, potentially saving tens of thousands of lives. An initial 18m doses of the world’s first malaria vaccine have been assigned to the countries where the risk of children falling ill and dying from malaria is highest, according to a statement from the global vaccine alliance Gavi, the World Health Organization (WHO) and Unicef.

Anew cancer therapy developed at Jerusalem’s Hadassah-University Medical Center had a 90% response rate in a new clinical trial, with over half of patients going into total remission. The CAR-T therapy — which arms the body’s own immune cells to fight cancer — was able to send multiple myeloma, an extremely deadly cancer that impacts the immune system, into remission.

In an ‘historic’ first, scientists freeze, thaw, and transplant rat organs — bringing transplant medicine one step closer to sci-fi dreams of stopping biological time.

Researchers at the University of Pennsylvania have found a way to harvest insulin grown in lettuce — and unlike today’s synthetic insulin, this kind wouldn’t require any painful injections. The challenge: Our bodies use the hormone insulin to convert sugar in our blood into energy. People with type 1 diabetes make little to no insulin naturally, so they have to inject synthetic insulin, and some people with type 2 need insulin shots, as well.

Toni Dezomits, a 55-year-old retired law enforcement officer, is fighting a recurrence of her stage 4 ovarian cancer. She had already undergone several rounds of chemotherapy when her doctor told her she had some more bad news. Just a day before her third round of treatment last month, Ms Dezomits was told there was a nationwide shortage of the generic chemotherapy drug, carboplatin - one of three medications she was meant to receive.

Most wound dressings simply cover the injury and perhaps also kill harmful bacteria. The PAINT system goes much further, as it incorporates a pen that could one day allow doctors to paint a gelatinous healing ink right into wounds. Its name an acronym for "portable bioactive ink for tissue healing," the PAINT technology is being developed by scientists from China's Nanjing University.

Not all surgical incisions are the same.